Working to Eradicate Gynecologic Cancers

EF4
Education Forum IV: Strategies for Managing Women at High Risk for Developing Ovarian Cancer: Considerations and Controversies for Current Practice

Sunday, March 29, 2015: 4:00 PM-5:15 PM
International Ballroom (Hilton Chicago)
Description: Knowledge of a woman's BRCA mutation status is gaining greater clinical utility and genetic testing is increasingly performed but which women should be tested for germline mutations and what can be done for her and her family if a mutation is found? This course will encompass the selection of women for testing for germline BRCA1/2 mutations or other high-risk genes, cancer risk management strategies for high risk women including the role of salpingectomy, and long term follow-up after risk-reducing surgery. The course will also address a broader set of issues facing families where a BRCA mutation has been detected including genetic testing for family members, cancers other than breast and ovarian cancer, male BRCA mutation carriers and the role of pre-implantation genetic diagnosis (PGD) as part of family planning decisions.
Course Directors:  Elizabeth M. Swisher, MD, University of Washington, Seattle, WA and Jessica N. McAlpine, MD, University of British Columbia, Vancouver, BC, Canada
Faculty:  Gillian Mitchell, MBBS, PhD, BC Cancer Agency, Vancouver, BC, Canada, Elizabeth M. Swisher, MD, University of Washington, Seattle, WA and Jessica N. McAlpine, MD, University of British Columbia, Vancouver, BC, Canada
4:00 PM
Welcoming Remarks
J. N. McAlpine1 and E. M. Swisher2
1University of British Columbia, Vancouver, BC, Canada, 2University of Washington, Seattle, WA
 
4:05 PM
4:25 PM
Strategies for managing women at high risk for developing ovarian cancer: surgical considerations
J. N. McAlpine
University of British Columbia, Vancouver, BC, Canada
 
4:45 PM
Identifying hereditary gynecologic cancer risk, BRCA1, BRCA2 and beyond
E. M. Swisher
University of Washington, Seattle, WA
 
5:05 PM
Discussion
 
See more of: Education Forum